GlassScriptPhysician profile
Brian P Peppel
NPI 1487021200
$532.54
in general payments reported to CMS, 2019-2025
17 companies · $62.64 in 2025
The $62.64 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.30 · 2022: $109 · 2023: $146 · 2024: $148 · 2025: $62.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $81.21 | 2023-2025 | Gattex |
| Merck Sharp & Dohme LLC | $76.37 | 2022-2025 | Bridion |
| Alexion Pharmaceuticals, INC. | $48.94 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $34.49 | 2023 | Andexxa |
| Smith+Nephew, INC. | $33.71 | 2022-2023 | Renasys Touch |
| Organogenesis INC. | $32.38 | 2024 | |
| Becton, Dickinson and Company | $32.24 | 2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $24.69 | 2021 | |
| Innocoll Pharmaceuticals Limited | $24.22 | 2022 | |
| La Jolla Pharmaceutical Company | $23.25 | 2021 | |
| Braintree Laboratories, INC. | $22.53 | 2023 | Sutab, Suflave |
| Baxter Healthcare | $22.25 | 2024 | Tisseel |
| Pacira Pharmaceuticals Incorporated | $18.36 | 2021 | |
| Integra Lifesciences Corporation | $17.54 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Medtronic, INC. | $13.68 | 2025 | Signia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.47 | 2023 | Spyglass Discover |
| Teleflex LLC | $13.21 | 2024 | Deknatel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Peppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.